Piperazino-derivatives and their use as PDE4 inhibitor

Details Piperazino-derivatives and their use as PDE4 inhibitor Piperazino-derivatives and their use as PDE4 inhibitor

2006-04-04

2006-04-04

Bernhardt, Emily (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S237800, C540S575000, C544S237000

Reexamination Certificate

active

07022696

ABSTRACT:
The compounds of formula Iin which R1, R2, R3, A, X, s and R9 have the meanings as given in the description are novel effective PDE4 inhibitors.

REFERENCES:
patent: 5716954 (1998-02-01), Wilhelm et al.
patent: 5859008 (1999-01-01), Jonas et al.
patent: 6103718 (2000-08-01), Sterk
patent: 6255303 (2001-07-01), Sterk
patent: 6380196 (2002-04-01), Ulrich et al.
patent: 6544993 (2003-04-01), Sterk
patent: 2004/0127707 (2004-07-01), Sterk
patent: 0763534 (1996-09-01), None
patent: 0934933 (1999-08-01), None
patent: WO 93/07146 (1993-04-01), None
patent: WO 94/12461 (1994-06-01), None
patent: WO 98/31674 (1998-07-01), None
patent: WO 99/31071 (1999-06-01), None
patent: WO 99/31090 (1999-06-01), None
patent: WO99/47505 (1999-09-01), None
patent: WO 01/19818 (2001-03-01), None
patent: WO 01/30766 (2001-05-01), None
patent: WO 01/30777 (2001-05-01), None
patent: WO 01/94319 (2001-12-01), None
Dyke et al. Expert Opin. Investig.Drugs, vol. 11(1), p. 1-13 (2002).
U.S. Appl. No. 10/467,832, filed Aug. 13, 2003, Grundler et al.
U.S. Appl. No. 10/475,657, filed Oct. 23, 2003, Sterk.
Van der Mey, et al., “Novel Selective PDE4 Inhibitors. 1. Synthesis, Structure—Activity Relationships, and Molecular Modeling of 4-(3,4-dimethoxyphenyl)-2H phthalazin-1-ones and Analogues”, J. Med. Chem., 44, p. 2511-2522 (2001).
Van der Mey, et al., “Novel Selective PDE4 Inhibitors. 2. Synthesis and Structure—Activity Relationships of 4-Aryl-Substituted cis-tetra and cis-Hexahydrophthalazinones”, J. Med. Chem., 44, p. 2523-2535 (2001).
Van der Mey, et al., “Novel Selective PDE4 Inhibitors. 3. In vivo Antiinflammatory Activity of a New Series of N-Substituted cis-Tetra and cis-Hexahydrophthalazinones”, J. Med. Chem., 45, p. 2520-2525 (2002).
Van der Mey, et al., “Novel Selective Phosphodiesterase (PDE4) Inhibitors. 4. Resolution, Absolute Configuration and PDE4 Inhibitory Activity of cis-Tetra and cis-Hexahydrophthalazinones”, J. Med. Chem., 45, p. 2526-2533 (2002).
Patent Abstracts of Japan, JP01019077A, Jan. 23, 1989.
Montana, et al. “Phosphodiesterase 4 Inhibitors”Cardiovascular and Pulmonary Diseases, Chapter 5, pp. 41-56 (2001).
Souness, et al. “Immunosuppresive and anti-inflammatory effects of cyclic AMP phosphodiesterase (PDE) type 4 inhibitors”,Immunopharmacology47 (2000) pp. 127-162.

Affiliated with

Also associated with

Rating

Piperazino-derivatives and their use as PDE4 inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Piperazino-derivatives and their use as PDE4 inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperazino-derivatives and their use as PDE4 inhibitor will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3584737